RedHill Biopharma announced that the FDA has approved Talicia (omeprazole magnesium, amoxicillin and rifabutin) delayed-release capsules 10 mg1/250 mg/12.5 mg...
Mycobutin is indicated for: - the prophylaxis of M. avium intracellulare complex (MAC) infections in patients with HIV disease with CD4 counts lower than 75 cells/mcl. - the treatment of non-tuberculous mycobacterial disease (such as that caused by MAC and M. xenopi). - pulmonary tuberculosis.